| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/18/2014 | WO2014144781A1 Combination therapy |
| 09/18/2014 | WO2014144623A1 Isolation of factor h from fraction i paste |
| 09/18/2014 | WO2014144610A1 Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
| 09/18/2014 | WO2014143638A1 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases |
| 09/18/2014 | WO2014143592A1 Inhibition of neovascularization by inhibition of prostanoid ip receptors |
| 09/18/2014 | WO2014143591A1 Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors |
| 09/18/2014 | WO2014143022A1 Compositions and methods for treating retinal disease |
| 09/18/2014 | WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor |
| 09/18/2014 | WO2014142146A1 Therapeutic agent for meibomian dysfunction |
| 09/18/2014 | WO2014142127A1 Phenylxanthene derivative |
| 09/18/2014 | WO2014142012A1 Ophthalmic composition for soft contact lens |
| 09/18/2014 | WO2014140075A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
| 09/18/2014 | WO2014140051A1 Mir-204 and mir-211 and uses thereof |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/17/2014 | EP2777699A1 Use of 2,5-dihydroxbencene sulfonic acid (dobesilate) for the treatment of age-related macular degeneration |
| 09/17/2014 | EP2777698A1 Compositions for Treating Hearing Loss |
| 09/17/2014 | EP2777693A1 Biodegradable ocular implants with long-term release characteristics |
| 09/17/2014 | EP2776565A1 Methods and compositions for treating diseases, disorders or injury of the nervous system |
| 09/17/2014 | EP2776442A1 [1, 2, 3]triazolo [4, 5 -d]pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 09/17/2014 | EP2776427A1 Modulators of atp-binding cassette transporters |
| 09/17/2014 | EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 09/17/2014 | EP2776389A1 Aryl urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 09/17/2014 | EP2776041A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11ß-17-21-TRIOL-3,20-DIONE DERIVATIVES |
| 09/17/2014 | EP2776040A1 4 - pregenen- 11ss -17- 21-triol-3,20-dione derivatives for the treatment of ocular conditions |
| 09/16/2014 | US8835525 Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835430 2,4-pyrimidinediamine compounds and their uses |
| 09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 09/12/2014 | WO2014138437A1 Steroid conjugates |
| 09/12/2014 | WO2014138425A1 Cyclosporine a-steroid conjugates |
| 09/12/2014 | WO2014138403A1 Antibiotic conjugates |
| 09/12/2014 | WO2014138375A1 Antibiotic conjugates linked with steroid drugs |
| 09/12/2014 | WO2014138359A1 Steroid antibiotic conjugates |
| 09/12/2014 | WO2014138350A1 Antibiotic conjugates directly linked with steroid drugs |
| 09/12/2014 | WO2014138343A1 Antibiotic conjugates with nonsteroidal anti-inflammatory drugs |
| 09/12/2014 | WO2014138085A1 Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery |
| 09/12/2014 | WO2014138037A1 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases |
| 09/12/2014 | WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies |
| 09/12/2014 | WO2014135123A1 17α-ethynyl-androst-5-ene-3β,7β,17β-triol ophthalmic preparation |
| 09/12/2014 | WO2014134922A1 Meloxicam eye drops and preparation method and use thereof |
| 09/12/2014 | WO2014134689A1 Polymer conjugate for delivery of a bioactive agent |
| 09/10/2014 | EP2773758A2 Methods and compositions for neuroprotection |
| 09/10/2014 | EP2773350A1 A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent |
| 09/09/2014 | US8828973 Compounds as receptor modulators with therapeutic utility |
| 09/09/2014 | US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor |
| 09/09/2014 | US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 09/04/2014 | WO2014131815A1 Peptides for use in the topical treatment of retinal neurodegenerative disesases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2770989A1 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 09/02/2014 | US8822685 2,4-pyrimidinediamine compounds and their uses |
| 09/02/2014 | US8822637 Somatostatin analogues |
| 09/02/2014 | US8822636 Peptides for activation and inhibition of δPKC |
| 09/02/2014 | US8822410 Tympanic membrane permeating ear drops and uses thereof |
| 09/02/2014 | US8821874 KLK-13 antibody inhibitor for treating dry eye |
| 09/02/2014 | CA2645488C Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| 08/28/2014 | WO2014130998A1 Surface functionalized porous silicon |
| 08/28/2014 | WO2014130947A1 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/28/2014 | WO2014130894A1 Compositions for the treatment of inflammatory diseases |
| 08/28/2014 | WO2014130550A1 Substituted diaryl derivatives as sphingosine receptor modulators |
| 08/28/2014 | WO2014130518A1 Abcb5(+) stem cells for treating ocular disease |
| 08/28/2014 | WO2014129969A1 Therapeutic agents |
| 08/28/2014 | US20140243413 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 08/28/2014 | US20140243284 Biologically active macrolides, compositions, and uses thereof |
| 08/27/2014 | EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 08/27/2014 | EP2769718A1 Medicinal composition |
| 08/27/2014 | EP2768809A1 Pyridine- sulfoximines as tyrosine kinase inhibitors |
| 08/27/2014 | EP2768504A1 Compositions for controlling vascularization in ophthalmological and dermatological diseases |
| 08/26/2014 | US8815821 Double-stranded oligonucleotides |
| 08/26/2014 | US8815268 Oat extracts: refining, compositions and methods of use |
| 08/26/2014 | CA2765852C Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
| 08/21/2014 | WO2014127164A1 Substituted dihydropyrazoles as sphingosine receptor modulators |
| 08/21/2014 | WO2014127007A1 Ophthalmic formulation derived from silk protein |
| 08/21/2014 | WO2014126997A1 Glaucoma treatment |
| 08/21/2014 | WO2014126267A1 Difluprednate emulsion composition containing antimicrobial metal |
| 08/21/2014 | WO2014126266A1 Difluprednate emulsion composition containing zinc |
| 08/21/2014 | WO2014124487A1 Ligand binding molecules and uses thereof |
| 08/21/2014 | US20140235721 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 08/20/2014 | EP2766393A1 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE |
| 08/20/2014 | EP2765992A1 Foam formulations |
| 08/20/2014 | EP2765987A1 Compositions for the treatment of dry eye |
| 08/20/2014 | EP2765986A1 Prevention and treatment of ocular conditions |
| 08/19/2014 | US8809326 Isoquinolinone Rho kinase inhibitors |
| 08/19/2014 | CA2651022C 12-aryl or heteroaryl prostaglandin analogs |
| 08/19/2014 | CA2475338C Treatment of ophthalmic disorders using urea and urea derivatives |
| 08/19/2014 | CA2375106C Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation |
| 08/14/2014 | WO2014101295A3 Isoxazole derivative that inhibits activity of janus kinases (jaks) |
| 08/14/2014 | US20140227341 Methods of using regenerative cells to promote wound healing |
| 08/14/2014 | US20140227234 Methods of using regenerative cells to promote wound healing |
| 08/13/2014 | EP2765188A1 Method for producing corneal endothelial cell |
| 08/13/2014 | EP2763654A1 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid |
| 08/13/2014 | CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives |
| 08/13/2014 | CN103981057A 解暑酒的制备工艺 Preparation of hot weather wine |
| 08/13/2014 | CN103980480A 一种接枝药物的聚合物的制备和用途 Preparation and use of a graft polymer of drug |
| 08/13/2014 | CN103980262A 卡格列净的b晶型及其结晶制备方法 Kage column net b polymorph and crystallization preparation |
| 08/13/2014 | CN103980261A 卡格列净的a晶型及其结晶制备方法 Kage column net of a crystalline polymorph its preparation method |
| 08/13/2014 | CN103977237A 一种治疗甲状腺的中药 A method of treating thyroid medicine |
| 08/13/2014 | CN103977211A 一种治疗和预防近视的药物 A method of treating and preventing myopia drugs |
| 08/13/2014 | CN103977185A 一种治疗麦粒肿的中药 A stye of traditional Chinese medicine |
| 08/13/2014 | CN103977167A 一种治疗老花眼的中药制剂 A method for treating presbyopia Chinese medicine |
| 08/13/2014 | CN103977161A 一种治疗白内障的中药 A traditional Chinese medicine treatment of cataract |